Fetal megacystis-microcolon: Genetic mutational spectrum and identification of PDCL3 as a novel candidate gene
- PMID: 32621347
- DOI: 10.1111/cge.13801
Fetal megacystis-microcolon: Genetic mutational spectrum and identification of PDCL3 as a novel candidate gene
Abstract
Megacystis-microcolon-intestinal-hypoperistalsis syndrome (MMIHS) is a severe congenital visceral myopathy characterized by an abdominal distension due to a large non-obstructed urinary bladder, a microcolon and intestinal hypo- or aperistalsis. Most of the patients described to date carry a sporadic heterozygous variant in ACTG2. More recently, recessive forms have been reported and mutations in MYH11, LMOD1, MYLK and MYL9 have been described at the molecular level. In the present report, we describe five patients carrying a recurrent heterozygous variant in ACTG2. Exome sequencing performed in four families allowed us to identify the genetic cause in three. In two families, we identified variants in MMIHS causal genes, respectively a nonsense homozygous variant in MYH11 and a previously described homozygous deletion in MYL9. Finally, we identified compound heterozygous variants in a novel candidate gene, PDCL3, c.[143_144del];[380G>A], p.[(Tyr48Ter)];[(Cys127Tyr)]. After cDNA analysis, a complete absence of PDLC3 expression was observed in affected individuals, indicating that both mutated transcripts were unstable and prone to mediated mRNA decay. PDCL3 encodes a protein involved in the folding of actin, a key step in thin filament formation. Presumably, loss-of-function of this protein affects the contractility of smooth muscle tissues, making PDCL3 an excellent candidate gene for autosomal recessive forms of MMIHS.
Keywords: MMIHS; PDCL3; fetus; phosducin-like protein; smooth muscle.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome.Eur J Hum Genet. 2018 May;26(5):669-675. doi: 10.1038/s41431-017-0055-5. Epub 2018 Feb 16. Eur J Hum Genet. 2018. PMID: 29453416 Free PMC article.
-
Compound heterozygous loss of function variants in MYL9 in a child with megacystis-microcolon-intestinal hypoperistalsis syndrome.Mol Genet Genomic Med. 2020 Nov;8(11):e1516. doi: 10.1002/mgg3.1516. Epub 2020 Oct 8. Mol Genet Genomic Med. 2020. PMID: 33031641 Free PMC article.
-
A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome.Eur J Hum Genet. 2015 Sep;23(9):1266-8. doi: 10.1038/ejhg.2014.256. Epub 2014 Nov 19. Eur J Hum Genet. 2015. PMID: 25407000 Free PMC article.
-
Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.Am J Med Genet A. 2016 Nov;170(11):2965-2974. doi: 10.1002/ajmg.a.37857. Epub 2016 Aug 2. Am J Med Genet A. 2016. PMID: 27481187 Free PMC article. Review.
-
Exploring the complexities of megacystis-microcolon-intestinal hypoperistalsis syndrome: insights from genetic studies.Clin J Gastroenterol. 2024 Jun;17(3):383-395. doi: 10.1007/s12328-024-01934-x. Epub 2024 Mar 9. Clin J Gastroenterol. 2024. PMID: 38461165 Review.
Cited by
-
A structural vista of phosducin-like PhLP2A-chaperonin TRiC cooperation during the ATP-driven folding cycle.Nat Commun. 2024 Feb 2;15(1):1007. doi: 10.1038/s41467-024-45242-x. Nat Commun. 2024. PMID: 38307855 Free PMC article.
-
Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy.Sci Adv. 2024 May 31;10(22):eadn6615. doi: 10.1126/sciadv.adn6615. Epub 2024 May 31. Sci Adv. 2024. PMID: 38820162 Free PMC article.
-
Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.Front Immunol. 2023 Mar 15;14:1128151. doi: 10.3389/fimmu.2023.1128151. eCollection 2023. Front Immunol. 2023. PMID: 37006287 Free PMC article.
-
Mutations in Hsp90 Cochaperones Result in a Wide Variety of Human Disorders.Front Mol Biosci. 2021 Dec 8;8:787260. doi: 10.3389/fmolb.2021.787260. eCollection 2021. Front Mol Biosci. 2021. PMID: 34957217 Free PMC article. Review.
-
Genome-wide analysis identifies MYH11 compound heterozygous variants leading to visceral myopathy corresponding to late-onset form of megacystis-microcolon-intestinal hypoperistalsis syndrome.Mol Genet Genomics. 2024 Apr 16;299(1):44. doi: 10.1007/s00438-024-02136-3. Mol Genet Genomics. 2024. PMID: 38625590
References
REFERENCES
-
- Puri P, Shinkai M. Megacystis microcolon intestinal hypoperistalsis syndrome. Semin Pediatr Surg. 2005;14(1):58-63.
-
- Muller F, Dreux S, Vaast P, et al. Prenatal diagnosis of megacystis-microcolon-intestinal hypoperistalsis syndrome: contribution of amniotic fluid digestive enzyme assay and fetal urinalysis. Prenat Diagn. 2005;25(3):203-209. https://doi.org/10.1002/pd.1088.
-
- Gosemann J-H, Puri P. Megacystis microcolon intestinal hypoperistalsis syndrome: systematic review of outcome. Pediatr Surg Int. 2011;27(10):1041-1046. https://doi.org/10.1007/s00383-011-2954-9.
-
- Thorson W, Diaz-Horta O, Foster J, et al. De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis. Hum Genet. 2014;133(6):737-742. https://doi.org/10.1007/s00439-013-1406-0.
-
- Wangler MF, Gonzaga-Jauregui C, Gambin T, et al. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. PLoS Genet. 2014;10(3):e1004258. https://doi.org/10.1371/journal.pgen.1004258.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Molecular Biology Databases